CN Patent
CN108727453A — 新型pd-1抑制剂及其应用
Assigned to East China University of Science and Technology · Expires 2018-11-02 · 8y expired
What this patent protects
本发明涉及作为PD‑1阻断剂的甾体类衍生物及其应用。具体而言,本发明涉及下式I所示化合物、含有下式I化合物的药物组合物及所述化合物在治疗PD‑1介导的相关疾病以及制备治疗PD‑1介导相关疾病的药物中的用途:
USPTO Abstract
本发明涉及作为PD‑1阻断剂的甾体类衍生物及其应用。具体而言,本发明涉及下式I所示化合物、含有下式I化合物的药物组合物及所述化合物在治疗PD‑1介导的相关疾病以及制备治疗PD‑1介导相关疾病的药物中的用途:
Drugs covered by this patent
- Zurzuvae (ZURANOLONE) · Biogen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.